Topical oxygen treatment for wound healing: a review of clinical and cost-effectiveness

CADTH
Record ID 32012000650
English
Authors' recommendations: While TWO2 heals 80% of diabetic foot ulcers (DFU), refractory venous ulcers (RVU) and chronic wounds without recurrence, its place in therapy cannot be fully determined as the absence of randomization and blinding prevent direct comparison between groups. No evidence was found regarding the cost-effectiveness of TWO2 compared with HBOT or conventional wound care.
Details
Project Status: Completed
Year Published: 2012
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Humans
  • Oxygen
  • Wound Healing
  • Administration, Topical
Contact
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.